This is the authors' abstract. We don't add key points for this paper.
Intravesical HA therapy is safe and effective for most (~60%) of our patients with refractory IC. Functional bladder capacity and Pain-VAS scores before treatment, and the early treatment responses are helpful predictors of treatment outcomes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: